Please assess the completion status of the following clinical trial:

Trial Title: Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Biopsy proven symptomatic vulvar lichen sclerosus~* Ability to understand the study, accept randomization and logistically follow-up with scheduled visits~* English Speaking~Exclusion Criteria:~* Known vulvar malignancy~* Pregnancy or planning pregnancy or less than 3 months postpartum~* Premenopausal~* Current or prior diagnosis of any gynecologic malignancy~* Previous pelvic radiation therapy~* Allergy to topical steroid~* Active Urinary Tract Infection (UTI), vulvar infection (candida, herpes, bacterial vaginosis, trichomoniasis or other infection)~* Pelvic organ prolapse \> than Stage 2~* Treatment with systemic immunomodulators, topical calcineurin inhibitors (tacrolimus, pimecrolimus), or vaginal hormonal or vulvar topical steroid use within 2 months of enrollment~* History of transvaginal mesh implant (excluding sling or sacrocolpopexy mesh)~* IUD (Intrauterine Device)~* Skindex-29 overall score \<21, below mildly impaired health related quality of life threshold

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prior Clobetasol Exposure (Type: EXPERIMENTAL): Patients with biopsy proven lichen sclerosus previously treated with clobetasol propionate
- No Prior Clobetasol Exposure (Type: ACTIVE_COMPARATOR): Patients with biopsy proven lichen sclerosus never previously treated with clobetasol propionate.

Based on this trial design, predict the completion outcome and termination type (if applicable).